Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)

Jae Cheol Jo; Jin Seok Kim; Je Hwan Lee; Jung Hee Lee; Sung Nam Lim; Sang Min Lee; Sung Soo Yoon; In Ho Kim; Sung Hwa Bae; Yoo Jin Lee; Yunsuk Choi; Won Sik Lee

doi:10.1038/s41409-020-0908-3

Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)

Jae Cheol Jo, Jin Seok Kim, Je Hwan Lee, Jung Hee Lee, Sung Nam Lim, Sang Min Lee, Sung Soo Yoon, In Ho Kim, Sung Hwa Bae, Yoo Jin Lee, Yunsuk Choi, Won Sik Lee

Department of Internal Medicine

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	1466-1468
Number of pages	3
Journal	Bone Marrow Transplantation
Volume	55
Issue number	7
DOIs	https://doi.org/10.1038/s41409-020-0908-3
Publication status	Published - 2020 Jul 1

All Science Journal Classification (ASJC) codes

Hematology
Transplantation

Access to Document

10.1038/s41409-020-0908-3

Cite this

Jo, J. C., Kim, J. S., Lee, J. H., Lee, J. H., Lim, S. N., Lee, S. M., Yoon, S. S., Kim, I. H., Bae, S. H., Lee, Y. J., Choi, Y., & Lee, W. S. (2020). Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL). Bone Marrow Transplantation, 55(7), 1466-1468. https://doi.org/10.1038/s41409-020-0908-3

@article{805639be994e497a96720a7835a13fe7,

title = "Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)",

author = "Jo, {Jae Cheol} and Kim, {Jin Seok} and Lee, {Je Hwan} and Lee, {Jung Hee} and Lim, {Sung Nam} and Lee, {Sang Min} and Yoon, {Sung Soo} and Kim, {In Ho} and Bae, {Sung Hwa} and Lee, {Yoo Jin} and Yunsuk Choi and Lee, {Won Sik}",

year = "2020",

month = jul,

day = "1",

doi = "10.1038/s41409-020-0908-3",

language = "English",

volume = "55",

pages = "1466--1468",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Nature Publishing Group",

number = "7",

}

Jo, JC, Kim, JS, Lee, JH, Lee, JH, Lim, SN, Lee, SM, Yoon, SS, Kim, IH, Bae, SH, Lee, YJ, Choi, Y & Lee, WS 2020, 'Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)', Bone Marrow Transplantation, vol. 55, no. 7, pp. 1466-1468. https://doi.org/10.1038/s41409-020-0908-3

TY - JOUR

T1 - Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)

AU - Jo, Jae Cheol

AU - Kim, Jin Seok

AU - Lee, Je Hwan

AU - Lee, Jung Hee

AU - Lim, Sung Nam

AU - Lee, Sang Min

AU - Yoon, Sung Soo

AU - Kim, In Ho

AU - Bae, Sung Hwa

AU - Lee, Yoo Jin

AU - Choi, Yunsuk

AU - Lee, Won Sik

PY - 2020/7/1

Y1 - 2020/7/1

UR - http://www.scopus.com/inward/record.url?scp=85083824754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083824754&partnerID=8YFLogxK

U2 - 10.1038/s41409-020-0908-3

DO - 10.1038/s41409-020-0908-3

M3 - Letter

C2 - 32303709

AN - SCOPUS:85083824754

SN - 0268-3369

VL - 55

SP - 1466

EP - 1468

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 7

ER -

Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this